Medical Care
Global Anosmia Market Research Report 2024
- Apr 15, 24
- ID: 168411
- Pages: 82
- Figures: 164
- Views: 22
Anosmia, also known as smell blindness, is the loss of the ability to detect one or more smells. Anosmia may be temporary or permanent. It differs from hyposmia, which is a decreased sensitivity to some or all smells.
The global Anosmia market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anosmia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anosmia.
Report Scope
The Anosmia market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anosmia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anosmia companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mylan N.V
Pfizer Inc
Atom Pharma
RANBAXY LABORATORIES LIMITED
Alde Medi Impex
GlaxoSmithkline Plc
Sandoz (Novasrtis AG)
Inke S.A.
Taj Pharmaceuticals Limited
Sanofi
Segment by Type
Therapies
Medications
Segment by Application
Idiopathic Anosmia
Congenital Anosmia
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anosmia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Anosmia market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anosmia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anosmia.
Report Scope
The Anosmia market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anosmia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anosmia companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mylan N.V
Pfizer Inc
Atom Pharma
RANBAXY LABORATORIES LIMITED
Alde Medi Impex
GlaxoSmithkline Plc
Sandoz (Novasrtis AG)
Inke S.A.
Taj Pharmaceuticals Limited
Sanofi
Segment by Type
Therapies
Medications
Segment by Application
Idiopathic Anosmia
Congenital Anosmia
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anosmia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anosmia Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Therapies
1.2.3 Medications
1.3 Market by Application
1.3.1 Global Anosmia Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Idiopathic Anosmia
1.3.3 Congenital Anosmia
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anosmia Market Perspective (2019-2030)
2.2 Anosmia Growth Trends by Region
2.2.1 Global Anosmia Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Anosmia Historic Market Size by Region (2019-2024)
2.2.3 Anosmia Forecasted Market Size by Region (2025-2030)
2.3 Anosmia Market Dynamics
2.3.1 Anosmia Industry Trends
2.3.2 Anosmia Market Drivers
2.3.3 Anosmia Market Challenges
2.3.4 Anosmia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anosmia Players by Revenue
3.1.1 Global Top Anosmia Players by Revenue (2019-2024)
3.1.2 Global Anosmia Revenue Market Share by Players (2019-2024)
3.2 Global Anosmia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anosmia Revenue
3.4 Global Anosmia Market Concentration Ratio
3.4.1 Global Anosmia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anosmia Revenue in 2023
3.5 Anosmia Key Players Head office and Area Served
3.6 Key Players Anosmia Product Solution and Service
3.7 Date of Enter into Anosmia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anosmia Breakdown Data by Type
4.1 Global Anosmia Historic Market Size by Type (2019-2024)
4.2 Global Anosmia Forecasted Market Size by Type (2025-2030)
5 Anosmia Breakdown Data by Application
5.1 Global Anosmia Historic Market Size by Application (2019-2024)
5.2 Global Anosmia Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Anosmia Market Size (2019-2030)
6.2 North America Anosmia Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Anosmia Market Size by Country (2019-2024)
6.4 North America Anosmia Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anosmia Market Size (2019-2030)
7.2 Europe Anosmia Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Anosmia Market Size by Country (2019-2024)
7.4 Europe Anosmia Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anosmia Market Size (2019-2030)
8.2 Asia-Pacific Anosmia Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Anosmia Market Size by Region (2019-2024)
8.4 Asia-Pacific Anosmia Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anosmia Market Size (2019-2030)
9.2 Latin America Anosmia Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Anosmia Market Size by Country (2019-2024)
9.4 Latin America Anosmia Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anosmia Market Size (2019-2030)
10.2 Middle East & Africa Anosmia Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Anosmia Market Size by Country (2019-2024)
10.4 Middle East & Africa Anosmia Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mylan N.V
11.1.1 Mylan N.V Company Detail
11.1.2 Mylan N.V Business Overview
11.1.3 Mylan N.V Anosmia Introduction
11.1.4 Mylan N.V Revenue in Anosmia Business (2019-2024)
11.1.5 Mylan N.V Recent Development
11.2 Pfizer Inc
11.2.1 Pfizer Inc Company Detail
11.2.2 Pfizer Inc Business Overview
11.2.3 Pfizer Inc Anosmia Introduction
11.2.4 Pfizer Inc Revenue in Anosmia Business (2019-2024)
11.2.5 Pfizer Inc Recent Development
11.3 Atom Pharma
11.3.1 Atom Pharma Company Detail
11.3.2 Atom Pharma Business Overview
11.3.3 Atom Pharma Anosmia Introduction
11.3.4 Atom Pharma Revenue in Anosmia Business (2019-2024)
11.3.5 Atom Pharma Recent Development
11.4 RANBAXY LABORATORIES LIMITED
11.4.1 RANBAXY LABORATORIES LIMITED Company Detail
11.4.2 RANBAXY LABORATORIES LIMITED Business Overview
11.4.3 RANBAXY LABORATORIES LIMITED Anosmia Introduction
11.4.4 RANBAXY LABORATORIES LIMITED Revenue in Anosmia Business (2019-2024)
11.4.5 RANBAXY LABORATORIES LIMITED Recent Development
11.5 Alde Medi Impex
11.5.1 Alde Medi Impex Company Detail
11.5.2 Alde Medi Impex Business Overview
11.5.3 Alde Medi Impex Anosmia Introduction
11.5.4 Alde Medi Impex Revenue in Anosmia Business (2019-2024)
11.5.5 Alde Medi Impex Recent Development
11.6 GlaxoSmithkline Plc
11.6.1 GlaxoSmithkline Plc Company Detail
11.6.2 GlaxoSmithkline Plc Business Overview
11.6.3 GlaxoSmithkline Plc Anosmia Introduction
11.6.4 GlaxoSmithkline Plc Revenue in Anosmia Business (2019-2024)
11.6.5 GlaxoSmithkline Plc Recent Development
11.7 Sandoz (Novasrtis AG)
11.7.1 Sandoz (Novasrtis AG) Company Detail
11.7.2 Sandoz (Novasrtis AG) Business Overview
11.7.3 Sandoz (Novasrtis AG) Anosmia Introduction
11.7.4 Sandoz (Novasrtis AG) Revenue in Anosmia Business (2019-2024)
11.7.5 Sandoz (Novasrtis AG) Recent Development
11.8 Inke S.A.
11.8.1 Inke S.A. Company Detail
11.8.2 Inke S.A. Business Overview
11.8.3 Inke S.A. Anosmia Introduction
11.8.4 Inke S.A. Revenue in Anosmia Business (2019-2024)
11.8.5 Inke S.A. Recent Development
11.9 Taj Pharmaceuticals Limited
11.9.1 Taj Pharmaceuticals Limited Company Detail
11.9.2 Taj Pharmaceuticals Limited Business Overview
11.9.3 Taj Pharmaceuticals Limited Anosmia Introduction
11.9.4 Taj Pharmaceuticals Limited Revenue in Anosmia Business (2019-2024)
11.9.5 Taj Pharmaceuticals Limited Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Detail
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Anosmia Introduction
11.10.4 Sanofi Revenue in Anosmia Business (2019-2024)
11.10.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anosmia Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Therapies
1.2.3 Medications
1.3 Market by Application
1.3.1 Global Anosmia Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Idiopathic Anosmia
1.3.3 Congenital Anosmia
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anosmia Market Perspective (2019-2030)
2.2 Anosmia Growth Trends by Region
2.2.1 Global Anosmia Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Anosmia Historic Market Size by Region (2019-2024)
2.2.3 Anosmia Forecasted Market Size by Region (2025-2030)
2.3 Anosmia Market Dynamics
2.3.1 Anosmia Industry Trends
2.3.2 Anosmia Market Drivers
2.3.3 Anosmia Market Challenges
2.3.4 Anosmia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anosmia Players by Revenue
3.1.1 Global Top Anosmia Players by Revenue (2019-2024)
3.1.2 Global Anosmia Revenue Market Share by Players (2019-2024)
3.2 Global Anosmia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anosmia Revenue
3.4 Global Anosmia Market Concentration Ratio
3.4.1 Global Anosmia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anosmia Revenue in 2023
3.5 Anosmia Key Players Head office and Area Served
3.6 Key Players Anosmia Product Solution and Service
3.7 Date of Enter into Anosmia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anosmia Breakdown Data by Type
4.1 Global Anosmia Historic Market Size by Type (2019-2024)
4.2 Global Anosmia Forecasted Market Size by Type (2025-2030)
5 Anosmia Breakdown Data by Application
5.1 Global Anosmia Historic Market Size by Application (2019-2024)
5.2 Global Anosmia Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Anosmia Market Size (2019-2030)
6.2 North America Anosmia Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Anosmia Market Size by Country (2019-2024)
6.4 North America Anosmia Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anosmia Market Size (2019-2030)
7.2 Europe Anosmia Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Anosmia Market Size by Country (2019-2024)
7.4 Europe Anosmia Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anosmia Market Size (2019-2030)
8.2 Asia-Pacific Anosmia Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Anosmia Market Size by Region (2019-2024)
8.4 Asia-Pacific Anosmia Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anosmia Market Size (2019-2030)
9.2 Latin America Anosmia Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Anosmia Market Size by Country (2019-2024)
9.4 Latin America Anosmia Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anosmia Market Size (2019-2030)
10.2 Middle East & Africa Anosmia Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Anosmia Market Size by Country (2019-2024)
10.4 Middle East & Africa Anosmia Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mylan N.V
11.1.1 Mylan N.V Company Detail
11.1.2 Mylan N.V Business Overview
11.1.3 Mylan N.V Anosmia Introduction
11.1.4 Mylan N.V Revenue in Anosmia Business (2019-2024)
11.1.5 Mylan N.V Recent Development
11.2 Pfizer Inc
11.2.1 Pfizer Inc Company Detail
11.2.2 Pfizer Inc Business Overview
11.2.3 Pfizer Inc Anosmia Introduction
11.2.4 Pfizer Inc Revenue in Anosmia Business (2019-2024)
11.2.5 Pfizer Inc Recent Development
11.3 Atom Pharma
11.3.1 Atom Pharma Company Detail
11.3.2 Atom Pharma Business Overview
11.3.3 Atom Pharma Anosmia Introduction
11.3.4 Atom Pharma Revenue in Anosmia Business (2019-2024)
11.3.5 Atom Pharma Recent Development
11.4 RANBAXY LABORATORIES LIMITED
11.4.1 RANBAXY LABORATORIES LIMITED Company Detail
11.4.2 RANBAXY LABORATORIES LIMITED Business Overview
11.4.3 RANBAXY LABORATORIES LIMITED Anosmia Introduction
11.4.4 RANBAXY LABORATORIES LIMITED Revenue in Anosmia Business (2019-2024)
11.4.5 RANBAXY LABORATORIES LIMITED Recent Development
11.5 Alde Medi Impex
11.5.1 Alde Medi Impex Company Detail
11.5.2 Alde Medi Impex Business Overview
11.5.3 Alde Medi Impex Anosmia Introduction
11.5.4 Alde Medi Impex Revenue in Anosmia Business (2019-2024)
11.5.5 Alde Medi Impex Recent Development
11.6 GlaxoSmithkline Plc
11.6.1 GlaxoSmithkline Plc Company Detail
11.6.2 GlaxoSmithkline Plc Business Overview
11.6.3 GlaxoSmithkline Plc Anosmia Introduction
11.6.4 GlaxoSmithkline Plc Revenue in Anosmia Business (2019-2024)
11.6.5 GlaxoSmithkline Plc Recent Development
11.7 Sandoz (Novasrtis AG)
11.7.1 Sandoz (Novasrtis AG) Company Detail
11.7.2 Sandoz (Novasrtis AG) Business Overview
11.7.3 Sandoz (Novasrtis AG) Anosmia Introduction
11.7.4 Sandoz (Novasrtis AG) Revenue in Anosmia Business (2019-2024)
11.7.5 Sandoz (Novasrtis AG) Recent Development
11.8 Inke S.A.
11.8.1 Inke S.A. Company Detail
11.8.2 Inke S.A. Business Overview
11.8.3 Inke S.A. Anosmia Introduction
11.8.4 Inke S.A. Revenue in Anosmia Business (2019-2024)
11.8.5 Inke S.A. Recent Development
11.9 Taj Pharmaceuticals Limited
11.9.1 Taj Pharmaceuticals Limited Company Detail
11.9.2 Taj Pharmaceuticals Limited Business Overview
11.9.3 Taj Pharmaceuticals Limited Anosmia Introduction
11.9.4 Taj Pharmaceuticals Limited Revenue in Anosmia Business (2019-2024)
11.9.5 Taj Pharmaceuticals Limited Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Detail
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Anosmia Introduction
11.10.4 Sanofi Revenue in Anosmia Business (2019-2024)
11.10.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Anosmia Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Therapies
Table 3. Key Players of Medications
Table 4. Global Anosmia Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Anosmia Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Anosmia Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Anosmia Market Share by Region (2019-2024)
Table 8. Global Anosmia Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Anosmia Market Share by Region (2025-2030)
Table 10. Anosmia Market Trends
Table 11. Anosmia Market Drivers
Table 12. Anosmia Market Challenges
Table 13. Anosmia Market Restraints
Table 14. Global Anosmia Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Anosmia Market Share by Players (2019-2024)
Table 16. Global Top Anosmia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anosmia as of 2023)
Table 17. Ranking of Global Top Anosmia Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Anosmia Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anosmia Product Solution and Service
Table 21. Date of Enter into Anosmia Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anosmia Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Anosmia Revenue Market Share by Type (2019-2024)
Table 25. Global Anosmia Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Anosmia Revenue Market Share by Type (2025-2030)
Table 27. Global Anosmia Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Anosmia Revenue Market Share by Application (2019-2024)
Table 29. Global Anosmia Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Anosmia Revenue Market Share by Application (2025-2030)
Table 31. North America Anosmia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Anosmia Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Anosmia Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Anosmia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Anosmia Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Anosmia Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Anosmia Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Anosmia Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Anosmia Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anosmia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Anosmia Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Anosmia Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Anosmia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Anosmia Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Anosmia Market Size by Country (2025-2030) & (US$ Million)
Table 46. Mylan N.V Company Detail
Table 47. Mylan N.V Business Overview
Table 48. Mylan N.V Anosmia Product
Table 49. Mylan N.V Revenue in Anosmia Business (2019-2024) & (US$ Million)
Table 50. Mylan N.V Recent Development
Table 51. Pfizer Inc Company Detail
Table 52. Pfizer Inc Business Overview
Table 53. Pfizer Inc Anosmia Product
Table 54. Pfizer Inc Revenue in Anosmia Business (2019-2024) & (US$ Million)
Table 55. Pfizer Inc Recent Development
Table 56. Atom Pharma Company Detail
Table 57. Atom Pharma Business Overview
Table 58. Atom Pharma Anosmia Product
Table 59. Atom Pharma Revenue in Anosmia Business (2019-2024) & (US$ Million)
Table 60. Atom Pharma Recent Development
Table 61. RANBAXY LABORATORIES LIMITED Company Detail
Table 62. RANBAXY LABORATORIES LIMITED Business Overview
Table 63. RANBAXY LABORATORIES LIMITED Anosmia Product
Table 64. RANBAXY LABORATORIES LIMITED Revenue in Anosmia Business (2019-2024) & (US$ Million)
Table 65. RANBAXY LABORATORIES LIMITED Recent Development
Table 66. Alde Medi Impex Company Detail
Table 67. Alde Medi Impex Business Overview
Table 68. Alde Medi Impex Anosmia Product
Table 69. Alde Medi Impex Revenue in Anosmia Business (2019-2024) & (US$ Million)
Table 70. Alde Medi Impex Recent Development
Table 71. GlaxoSmithkline Plc Company Detail
Table 72. GlaxoSmithkline Plc Business Overview
Table 73. GlaxoSmithkline Plc Anosmia Product
Table 74. GlaxoSmithkline Plc Revenue in Anosmia Business (2019-2024) & (US$ Million)
Table 75. GlaxoSmithkline Plc Recent Development
Table 76. Sandoz (Novasrtis AG) Company Detail
Table 77. Sandoz (Novasrtis AG) Business Overview
Table 78. Sandoz (Novasrtis AG) Anosmia Product
Table 79. Sandoz (Novasrtis AG) Revenue in Anosmia Business (2019-2024) & (US$ Million)
Table 80. Sandoz (Novasrtis AG) Recent Development
Table 81. Inke S.A. Company Detail
Table 82. Inke S.A. Business Overview
Table 83. Inke S.A. Anosmia Product
Table 84. Inke S.A. Revenue in Anosmia Business (2019-2024) & (US$ Million)
Table 85. Inke S.A. Recent Development
Table 86. Taj Pharmaceuticals Limited Company Detail
Table 87. Taj Pharmaceuticals Limited Business Overview
Table 88. Taj Pharmaceuticals Limited Anosmia Product
Table 89. Taj Pharmaceuticals Limited Revenue in Anosmia Business (2019-2024) & (US$ Million)
Table 90. Taj Pharmaceuticals Limited Recent Development
Table 91. Sanofi Company Detail
Table 92. Sanofi Business Overview
Table 93. Sanofi Anosmia Product
Table 94. Sanofi Revenue in Anosmia Business (2019-2024) & (US$ Million)
Table 95. Sanofi Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anosmia Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Anosmia Market Share by Type: 2023 VS 2030
Figure 3. Therapies Features
Figure 4. Medications Features
Figure 5. Global Anosmia Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Anosmia Market Share by Application: 2023 VS 2030
Figure 7. Idiopathic Anosmia Case Studies
Figure 8. Congenital Anosmia Case Studies
Figure 9. Anosmia Report Years Considered
Figure 10. Global Anosmia Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Anosmia Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Anosmia Market Share by Region: 2023 VS 2030
Figure 13. Global Anosmia Market Share by Players in 2023
Figure 14. Global Top Anosmia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anosmia as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Anosmia Revenue in 2023
Figure 16. North America Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Anosmia Market Share by Country (2019-2030)
Figure 18. United States Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Anosmia Market Share by Country (2019-2030)
Figure 22. Germany Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Anosmia Market Share by Region (2019-2030)
Figure 30. China Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Anosmia Market Share by Country (2019-2030)
Figure 38. Mexico Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Anosmia Market Share by Country (2019-2030)
Figure 42. Turkey Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Mylan N.V Revenue Growth Rate in Anosmia Business (2019-2024)
Figure 45. Pfizer Inc Revenue Growth Rate in Anosmia Business (2019-2024)
Figure 46. Atom Pharma Revenue Growth Rate in Anosmia Business (2019-2024)
Figure 47. RANBAXY LABORATORIES LIMITED Revenue Growth Rate in Anosmia Business (2019-2024)
Figure 48. Alde Medi Impex Revenue Growth Rate in Anosmia Business (2019-2024)
Figure 49. GlaxoSmithkline Plc Revenue Growth Rate in Anosmia Business (2019-2024)
Figure 50. Sandoz (Novasrtis AG) Revenue Growth Rate in Anosmia Business (2019-2024)
Figure 51. Inke S.A. Revenue Growth Rate in Anosmia Business (2019-2024)
Figure 52. Taj Pharmaceuticals Limited Revenue Growth Rate in Anosmia Business (2019-2024)
Figure 53. Sanofi Revenue Growth Rate in Anosmia Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Table 1. Global Anosmia Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Therapies
Table 3. Key Players of Medications
Table 4. Global Anosmia Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Anosmia Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Anosmia Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Anosmia Market Share by Region (2019-2024)
Table 8. Global Anosmia Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Anosmia Market Share by Region (2025-2030)
Table 10. Anosmia Market Trends
Table 11. Anosmia Market Drivers
Table 12. Anosmia Market Challenges
Table 13. Anosmia Market Restraints
Table 14. Global Anosmia Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Anosmia Market Share by Players (2019-2024)
Table 16. Global Top Anosmia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anosmia as of 2023)
Table 17. Ranking of Global Top Anosmia Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Anosmia Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anosmia Product Solution and Service
Table 21. Date of Enter into Anosmia Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anosmia Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Anosmia Revenue Market Share by Type (2019-2024)
Table 25. Global Anosmia Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Anosmia Revenue Market Share by Type (2025-2030)
Table 27. Global Anosmia Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Anosmia Revenue Market Share by Application (2019-2024)
Table 29. Global Anosmia Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Anosmia Revenue Market Share by Application (2025-2030)
Table 31. North America Anosmia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Anosmia Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Anosmia Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Anosmia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Anosmia Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Anosmia Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Anosmia Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Anosmia Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Anosmia Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anosmia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Anosmia Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Anosmia Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Anosmia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Anosmia Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Anosmia Market Size by Country (2025-2030) & (US$ Million)
Table 46. Mylan N.V Company Detail
Table 47. Mylan N.V Business Overview
Table 48. Mylan N.V Anosmia Product
Table 49. Mylan N.V Revenue in Anosmia Business (2019-2024) & (US$ Million)
Table 50. Mylan N.V Recent Development
Table 51. Pfizer Inc Company Detail
Table 52. Pfizer Inc Business Overview
Table 53. Pfizer Inc Anosmia Product
Table 54. Pfizer Inc Revenue in Anosmia Business (2019-2024) & (US$ Million)
Table 55. Pfizer Inc Recent Development
Table 56. Atom Pharma Company Detail
Table 57. Atom Pharma Business Overview
Table 58. Atom Pharma Anosmia Product
Table 59. Atom Pharma Revenue in Anosmia Business (2019-2024) & (US$ Million)
Table 60. Atom Pharma Recent Development
Table 61. RANBAXY LABORATORIES LIMITED Company Detail
Table 62. RANBAXY LABORATORIES LIMITED Business Overview
Table 63. RANBAXY LABORATORIES LIMITED Anosmia Product
Table 64. RANBAXY LABORATORIES LIMITED Revenue in Anosmia Business (2019-2024) & (US$ Million)
Table 65. RANBAXY LABORATORIES LIMITED Recent Development
Table 66. Alde Medi Impex Company Detail
Table 67. Alde Medi Impex Business Overview
Table 68. Alde Medi Impex Anosmia Product
Table 69. Alde Medi Impex Revenue in Anosmia Business (2019-2024) & (US$ Million)
Table 70. Alde Medi Impex Recent Development
Table 71. GlaxoSmithkline Plc Company Detail
Table 72. GlaxoSmithkline Plc Business Overview
Table 73. GlaxoSmithkline Plc Anosmia Product
Table 74. GlaxoSmithkline Plc Revenue in Anosmia Business (2019-2024) & (US$ Million)
Table 75. GlaxoSmithkline Plc Recent Development
Table 76. Sandoz (Novasrtis AG) Company Detail
Table 77. Sandoz (Novasrtis AG) Business Overview
Table 78. Sandoz (Novasrtis AG) Anosmia Product
Table 79. Sandoz (Novasrtis AG) Revenue in Anosmia Business (2019-2024) & (US$ Million)
Table 80. Sandoz (Novasrtis AG) Recent Development
Table 81. Inke S.A. Company Detail
Table 82. Inke S.A. Business Overview
Table 83. Inke S.A. Anosmia Product
Table 84. Inke S.A. Revenue in Anosmia Business (2019-2024) & (US$ Million)
Table 85. Inke S.A. Recent Development
Table 86. Taj Pharmaceuticals Limited Company Detail
Table 87. Taj Pharmaceuticals Limited Business Overview
Table 88. Taj Pharmaceuticals Limited Anosmia Product
Table 89. Taj Pharmaceuticals Limited Revenue in Anosmia Business (2019-2024) & (US$ Million)
Table 90. Taj Pharmaceuticals Limited Recent Development
Table 91. Sanofi Company Detail
Table 92. Sanofi Business Overview
Table 93. Sanofi Anosmia Product
Table 94. Sanofi Revenue in Anosmia Business (2019-2024) & (US$ Million)
Table 95. Sanofi Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anosmia Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Anosmia Market Share by Type: 2023 VS 2030
Figure 3. Therapies Features
Figure 4. Medications Features
Figure 5. Global Anosmia Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Anosmia Market Share by Application: 2023 VS 2030
Figure 7. Idiopathic Anosmia Case Studies
Figure 8. Congenital Anosmia Case Studies
Figure 9. Anosmia Report Years Considered
Figure 10. Global Anosmia Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Anosmia Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Anosmia Market Share by Region: 2023 VS 2030
Figure 13. Global Anosmia Market Share by Players in 2023
Figure 14. Global Top Anosmia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anosmia as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Anosmia Revenue in 2023
Figure 16. North America Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Anosmia Market Share by Country (2019-2030)
Figure 18. United States Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Anosmia Market Share by Country (2019-2030)
Figure 22. Germany Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Anosmia Market Share by Region (2019-2030)
Figure 30. China Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Anosmia Market Share by Country (2019-2030)
Figure 38. Mexico Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Anosmia Market Share by Country (2019-2030)
Figure 42. Turkey Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Anosmia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Mylan N.V Revenue Growth Rate in Anosmia Business (2019-2024)
Figure 45. Pfizer Inc Revenue Growth Rate in Anosmia Business (2019-2024)
Figure 46. Atom Pharma Revenue Growth Rate in Anosmia Business (2019-2024)
Figure 47. RANBAXY LABORATORIES LIMITED Revenue Growth Rate in Anosmia Business (2019-2024)
Figure 48. Alde Medi Impex Revenue Growth Rate in Anosmia Business (2019-2024)
Figure 49. GlaxoSmithkline Plc Revenue Growth Rate in Anosmia Business (2019-2024)
Figure 50. Sandoz (Novasrtis AG) Revenue Growth Rate in Anosmia Business (2019-2024)
Figure 51. Inke S.A. Revenue Growth Rate in Anosmia Business (2019-2024)
Figure 52. Taj Pharmaceuticals Limited Revenue Growth Rate in Anosmia Business (2019-2024)
Figure 53. Sanofi Revenue Growth Rate in Anosmia Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232